“Interesting that it's not posted--LL mentioned
Post# of 147784
(Total Views: 985)
Posted On: 11/13/2020 11:50:54 PM
“Interesting that it's not posted--LL mentioned over 60 times, I believe? You'd think *any* article that mentioned LL that much would be posted for sure.”
IMO, NP should combine the published clinical findings of leronlimab with the published laboratory findings from Dr. BP for some type of presentation. The two together provide peer reviewed, clinically and statistically significant data to support leronlimab’s role in the S/C population. What else do you need to drive the interest up for the S/C trial?
IMO, NP should combine the published clinical findings of leronlimab with the published laboratory findings from Dr. BP for some type of presentation. The two together provide peer reviewed, clinically and statistically significant data to support leronlimab’s role in the S/C population. What else do you need to drive the interest up for the S/C trial?
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼